MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ahj.2026.107339

Медицинская библиотека · American heart journal · 2026

Intravascular ultrasound guidance for complex high-risk indicated procedures: The IVUS CHIP trial study design.

Diletti Roberto, Daemen Joost, Faurie Benjamin, Barbierato Marco, Tchetche Didier, Hovasse Thomas, Teeuwen Koen, Oemrawsingh Rohit M, Allali Abdelhakim, Campo Gianluca, Bennett Johan, Alfonso Fernando, Mashayekhi Kambis, Moreno Raul, Abdelwahed Youssef S, Dedic Admir, de la Torre Hernandez Jose M, Murphy John C, Amat-Santos Ignacio, Dens Joseph, Franzé Alfonso, Leistner David, Ghattas Angie, Spratt James C, Banning Adrian P, Tijssen Jan G P, Spitzer Ernest, Van Mieghem Nicolas M, IVUS CHIP investigators

СтатьяПротокол клинического исследованияПеревод пока не подготовлен

Аннотация

BACKGROUND

Intravascular ultrasound (IVUS) guidance for percutaneous coronary intervention (PCI) has been associated with a reduction in clinical events. Whereas most evidence is generated in Asian-Pacific populations, its global adoption remains low.

METHODS

The IVUS complex high-risk indicated procedures (CHIP) trial is a multicenter, international, event-driven, randomized superiority trial comparing IVUS-guided PCI with angio-guided PCI during complex high-risk indicated procedures. The primary endpoint is target vessel failure, defined as a composite of cardiac death, target vessel myocardial infarction, or clinically indicated target vessel revascularization. The IVUS CHIP trial utilizes an event-driven approach. The outcomes for the primary endpoint are first reported when at least 169 patients with a primary endpoint have been confirmed. A total of 2020 patients will be enrolled in 37 European sites.

CONCLUSIONS

The aim of the IVUS CHIP trial is to assess the superiority of an IVUS-guided approach vs an angio-guided approach in patients undergoing complex high-risk indicated procedures in terms of the study primary endpoint of target vessel failure.

TRIAL REGISTRATION: The IVUS CHIP trial is registered at ClinicalTrial.gov and assigned the identifier NCT04854070.

Для цитирования: Diletti Roberto, Daemen Joost, Faurie Benjamin, Barbierato Marco, Tchetche Didier, Hovasse Thomas, Teeuwen Koen, Oemrawsingh Rohit M, Allali Abdelhakim, Campo Gianluca, Bennett Johan, Alfonso Fernando, Mashayekhi Kambis, Moreno Raul, Abdelwahed Youssef S, Dedic Admir, de la Torre Hernandez Jose M, Murphy John C, Amat-Santos Ignacio, Dens Joseph, Franzé Alfonso, Leistner David, Ghattas Angie, Spratt James C, Banning Adrian P, Tijssen Jan G P, Spitzer Ernest, Van Mieghem Nicolas M, IVUS CHIP investigators. Intravascular ultrasound guidance for complex high-risk indicated procedures: The IVUS CHIP trial study design.. American heart journal. 2026. DOI: 10.1016/j.ahj.2026.107339.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.